Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1988-6-13
pubmed:abstractText
The influence of two kinds of contraceptive pills, a sequential one and a combined one (Sequenz-Ovosiston and Minisiston), on serum lipoproteins and carbohydrate metabolism was investigated in 32 young patients who got these drugs for the first time during a period of 12 months. There were no pathological values of cholesterol, high density proteins, low density proteins, triglycerides or oral glucose tolerance test during and after the treatment. The authors summarized, that neither Sequenz-Ovosiston nor Minisiston increase the risk of atherosclerosis and of diabetes in young healthy women.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Blood Glucose, http://linkedlifedata.com/resource/pubmed/chemical/Chlormadinone Acetate, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Contraceptives, Oral, http://linkedlifedata.com/resource/pubmed/chemical/Contraceptives, Oral, Combined, http://linkedlifedata.com/resource/pubmed/chemical/Contraceptives, Oral, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Contraceptives, Oral, Sequential, http://linkedlifedata.com/resource/pubmed/chemical/Ethinyl Estradiol, http://linkedlifedata.com/resource/pubmed/chemical/Ethinyl Estradiol-Norgestrel..., http://linkedlifedata.com/resource/pubmed/chemical/Lipids, http://linkedlifedata.com/resource/pubmed/chemical/Lipoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Mestranol, http://linkedlifedata.com/resource/pubmed/chemical/Norgestrel, http://linkedlifedata.com/resource/pubmed/chemical/Ovosiston
pubmed:status
MEDLINE
pubmed:issn
0044-4197
pubmed:author
pubmed:issnType
Print
pubmed:volume
110
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
241-5
pubmed:dateRevised
2008-2-11
pubmed:meshHeading
pubmed-meshheading:2453102-Adolescent, pubmed-meshheading:2453102-Adult, pubmed-meshheading:2453102-Blood Glucose, pubmed-meshheading:2453102-Chlormadinone Acetate, pubmed-meshheading:2453102-Cholesterol, pubmed-meshheading:2453102-Contraceptives, Oral, pubmed-meshheading:2453102-Contraceptives, Oral, Combined, pubmed-meshheading:2453102-Contraceptives, Oral, Hormonal, pubmed-meshheading:2453102-Contraceptives, Oral, Sequential, pubmed-meshheading:2453102-Dose-Response Relationship, Drug, pubmed-meshheading:2453102-Ethinyl Estradiol, pubmed-meshheading:2453102-Ethinyl Estradiol-Norgestrel Combination, pubmed-meshheading:2453102-Female, pubmed-meshheading:2453102-Glucose Tolerance Test, pubmed-meshheading:2453102-Humans, pubmed-meshheading:2453102-Lipids, pubmed-meshheading:2453102-Lipoproteins, pubmed-meshheading:2453102-Mestranol, pubmed-meshheading:2453102-Norgestrel
pubmed:year
1988
pubmed:articleTitle
[Modification of serum lipids and glucose tolerance by sequential Ovosiston and Minisiston].
pubmed:affiliation
Klinik und Poliklinik für Gynäkologie und Geburtshilfe, Bereichs Medizin (Charité) der Humboldt-Universität.
pubmed:publicationType
Journal Article, English Abstract